NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.

Biotechnology

Professional Services

Software

Therapeutics

NeoPhore

NeoPhore's headquarters in Cambridge, United Kingdom

Martin Drysdale

Stephen Over

Julian Blagg

Pedro Rodriguez

Philippe Riou

Josep Tabernero

Giovanni Germano

Robert James

Alberto Bardelli

Luis Alberto Diaz Jr

John Haurum

Pietro Puglisi

The Leadership Team at NeoPhore drives the strategic vision and operational execution of the company's innovative cancer therapies. Comprising experts in drug discovery and scientific research, as well as seasoned executives in finance and corporate leadership, this team collaborates to advance the development of immune-stimulating treatments and ensure the company's growth and sustainability in the biopharmaceutical sector.

Leadership Team

The Scientific Team at NeoPhore spearheads the discovery and development of novel small molecule therapies aimed at treating cancer by stimulating the immune system. Comprising of distinguished experts and leaders in the field, including board members, founders, and executive officers, the team focuses on innovative research, strategic oversight, and advancing drug discovery initiatives.

Scientific Team

The Biology and Immunology team at NeoPhore focuses on researching and developing small molecule therapies that stimulate the immune system to fight cancer. This includes conducting preclinical studies, analyzing biological pathways, and identifying potential therapeutic targets to advance NeoPhore's innovative cancer treatments.

Biology and Immunology

NeoPhore

Org chart

Board & advisors

Teams

Leadership Team

Scientific Team

Biology and Immunology

Offices

NeoPhore

Org chart

Board & advisors

Teams

Leadership Team

Scientific Team

Biology and Immunology

Offices

Related companies